אוקסיקונטין 20 ישראל - עברית - Ministry of Health

אוקסיקונטין 20

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 20 mg - oxycodone - oxycodone - for the relief of moderate severe chronic pain.

אוקסיקונטין 10 ישראל - עברית - Ministry of Health

אוקסיקונטין 10

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 10 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

אוקסיקונטין 80 ישראל - עברית - Ministry of Health

אוקסיקונטין 80

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 80 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

אוקסיקונטין 40 ישראל - עברית - Ministry of Health

אוקסיקונטין 40

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 40 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

אוקסיקוד 2 מגמל סירופ ישראל - עברית - Ministry of Health

אוקסיקוד 2 מגמל סירופ

rafa laboratories ltd - oxycodone hydrochloride - סירופ - oxycodone hydrochloride 10 mg / 5 ml - oxycodone - oxycodone - for use in the relief of moderate to severe pain.

אוקסיקוד פורטה 10 מגמל סירופ ישראל - עברית - Ministry of Health

אוקסיקוד פורטה 10 מגמל סירופ

rafa laboratories ltd - oxycodone hydrochloride - סירופ - oxycodone hydrochloride 10 mg/ml - oxycodone - oxycodone - for the relief of moderate to severe pain.

אוקסיקונטין 5 מג ישראל - עברית - Ministry of Health

אוקסיקונטין 5 מג

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

אוקסיקונטין 5 מג ישראל - עברית - Ministry of Health

אוקסיקונטין 5 מג

rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

אקטוס 15 מג ישראל - עברית - Ministry of Health

אקטוס 15 מג

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

אקטוס 30 מג ישראל - עברית - Ministry of Health

אקטוס 30 מג

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 30 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi